Usefulness of Serum Cathepsin L as an Independent Biomarker in Patients With Coronary Heart Disease

This publication has 27 references indexed in Scilit:

• Superoxide-Dependent Cathepsin Activation Is Associated with Hypertensive Myocardial Remodeling and Represents a Target for Angiotensin II Type 1 Receptor Blocker Treatment
  The American Journal of Pathology, 2008
• Cathepsin L Deficiency Reduces Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor–Knockout Mice
  Circulation, 2007
• C-reactive protein in vulnerable coronary plaques
  Journal of Clinical Pathology, 2006
• Increased serum cathepsin S in patients with atherosclerosis and diabetes
  Atherosclerosis, 2006
• Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice
  The FASEB Journal, 2006
• Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells
  Atherosclerosis, 2006
• Lysosomal Cysteine Proteases in Atherosclerosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2004
• C-reactive Protein and Coronary Artery Disease
  Japanese Heart Journal, 2002
• Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction
  JACC, 2000
• A more meaningful scoring system for determining the severity of coronary heart disease
  The American Journal of Cardiology, 1983